Search other topics…

The Story of Lou Gehrig's Disease

Lou Gehrig, a name synonymous with baseball greatness, became an unexpected face for a devastating disease. Known as the 'Iron Horse' for his incredible stamina and dedication, Gehrig's life took a tragic turn when he was diagnosed with amyotrophic lateral sclerosis (ALS). This condition, now commonly called Lou Gehrig's disease, forever linked the sports hero to a battle against a relentless neurological disorder.

This article explores his journey from baseball icon to a symbol of hope and awareness for those affected by ALS.

What Were the Early Symptoms of Lou Gehrig’s Disease?

Even a player as famously robust as Lou Gehrig couldn't escape the subtle, then more pronounced, signs that something was amiss. While the official diagnosis of amyotrophic lateral sclerosis (ALS) wouldn't come until 1939, the seeds of the disease were likely present much earlier.

By the middle of the 1938 season, Gehrig himself started to notice changes. He mentioned feeling tired, a departure from his usual tireless performance.

Though his statistics for that year might seem strong to an outsider, they represented a dip from his peak years. This period marked the beginning of a noticeable decline in his physical capabilities.

How Were ALS Symptoms Perceived by Doctors in the 1930s?

In the 1930s, understanding of neurological conditions like ALS was far less advanced than it is today. When prominent athletes experienced unexplained physical declines, speculation often ran rampant.

For Gehrig, the press and fans noticed his struggles. Reporters observed him meeting the ball squarely but failing to generate his usual power. The inability to perform even routine plays, like a simple put-out at first base, became a significant concern.

Gehrig himself recognized these difficulties, acknowledging that a basic play felt unmanageable, signaling to him that a serious problem was at hand. The medical community at the time lacked the diagnostic tools and knowledge to quickly identify the specific cause of such progressive muscle weakness and coordination issues.

The 1939 Diagnosis That Gave a Disease Its Name

Why Did Lou Gehrig Visit the Mayo Clinic in 1939?

In 1939, as the baseball season was underway, Lou Gehrig began experiencing symptoms that were increasingly difficult to ignore. His usual coordination and strength seemed to be waning, impacting his performance on the field.

Concerned, Gehrig sought medical advice, leading him to the renowned Mayo Clinic in Rochester, Minnesota. It was there, after a series of examinations, that he received a diagnosis that would forever link his name to a devastating neurological condition.

What Was Known About Amyotrophic Lateral Sclerosis in 1939?

The diagnosis given to Gehrig was Amyotrophic Lateral Sclerosis, or ALS. At the time, ALS was a relatively poorly understood disease.

The name itself describes key aspects of the condition: 'Amyotrophic' refers to muscle wasting, 'Lateral' points to the location of nerve damage in the spinal cord, and 'Sclerosis' indicates the hardening or scarring of these affected areas.

Essentially, ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. These nerve cells, known as motor neurons, are responsible for controlling voluntary muscle movement.

As these neurons degenerate, the brain's ability to send signals to the muscles is impaired, leading to increasing weakness, paralysis, and eventually, respiratory failure. The exact cause of ALS remained unknown in 1939, and effective treatments were virtually nonexistent.

Why Is Lou Gehrig’s Farewell Speech So Significant to the ALS Community?

Despite the grim prognosis, Lou Gehrig chose to face his illness with remarkable courage and dignity. On July 4, 1939, during a New York Yankees home game, the team held a special ceremony to honor him.

It was on this day that Gehrig delivered what is now considered one of the most poignant speeches in sports history. Standing before a crowd of thousands, he expressed profound gratitude for his career and the support he had received, famously stating, "I consider myself the luckiest man on the face of the earth."

This speech, delivered with grace in the face of immense personal adversity, cemented Gehrig's status not just as a baseball legend, but as a symbol of resilience. His willingness to publicly acknowledge his condition, even as the disease progressed, brought unprecedented attention to ALS.

How Did Lou Gehrig’s Story Impact Public Awareness of ALS?

How Did One Athlete Bring Global Attention to a Rare Neurological Disease?

Lou Gehrig's diagnosis in 1939 thrust a little-known neurological condition into the national consciousness.

Before his story, Amyotrophic Lateral Sclerosis was a disease that affected individuals quietly, often without widespread public recognition. Gehrig's immense popularity as a baseball hero meant that his struggle with the illness immediately captured the attention of the American public.

His dignified and courageous approach to facing the disease, particularly during his famous farewell speech, made him a relatable and sympathetic figure. This public awareness was a significant shift from the disease's previous obscurity.

Why Did the Public Name the Condition ‘Lou Gehrig’s Disease’?

Following Gehrig's retirement and subsequent death from ALS in 1941, the disease became widely known as 'Lou Gehrig's Disease' in the United States.

This informal naming convention was a direct result of his public persona and the emotional connection people felt to his story. It was a way for the public to honor his memory and to have a more accessible term for a complex medical condition.

While the scientific community continued to use the term ALS, the public adopted 'Lou Gehrig's Disease' as a common reference, effectively humanizing the illness.

How Did Lou Gehrig’s Fame Benefit Early ALS Research and Advocacy?

Gehrig's celebrity status undeniably accelerated public awareness and, consequently, interest in research. The widespread media coverage of his illness and his passing brought attention to the need for understanding and treating ALS.

This increased visibility helped to galvanize support for early neuroscience research initiatives, even if the scientific understanding and treatment options at the time were limited. The emotional impact of his story encouraged donations and a general public willingness to learn more about the disease.

His legacy created a foundation for future advocacy and research efforts that continue to this day.

What Is the Lasting Legacy of Lou Gehrig and ALS?

Lou Gehrig's story is a powerful reminder of how a single individual's struggle can bring widespread attention to a devastating disease.

Even decades after his passing, his name remains synonymous with ALS, a connection that has spurred research and offered hope to countless individuals and families in the search for improving their brain health.

Frequently Asked Questions

How did Lou Gehrig get his name linked to ALS?

Lou Gehrig was diagnosed with ALS in 1939. Because he was such a well-known and admired athlete, the disease became widely known as 'Lou Gehrig's Disease' in the United States.

How did Lou Gehrig's fame help ALS awareness?

Because Lou Gehrig was a beloved sports hero, his story brought a lot of attention to ALS. This helped people learn about the disease and encouraged more support for research.

Is ALS a common disease?

ALS is considered a rare disease. In the United States, about 30,000 people are living with ALS at any given time.

What is the outlook for people diagnosed with ALS?

ALS is a serious disease, and unfortunately, it is fatal. Most people live about 3 to 5 years after being diagnosed, though some people can live longer.

Emotiv is a neurotechnology leader helping advance neuroscience research through accessible EEG and brain data tools.

Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical or health advice. This content may contain errors and should not be relied upon to make life-altering health, medical, or lifestyle choices. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment.

Christian Burgos

Latest from us

The Dry EEG Electrode Trade-Off: Speed and Comfort vs. Signal Fidelity

The electroencephalogram (EEG) has been a cornerstone of neuroscience for decades, measuring the brain’s electrical activity through electrodes placed on the scalp. Traditional “wet” electrodes require conductive gel to bridge the gap between skin and sensor, reducing the resistance—impedance—that would otherwise block these tiny voltages. That gel application is messy, time‑consuming, and often uncomfortable for participants.

As EEG moves outside the laboratory—into homes, clinics, and ambulatory settings—the demand for a faster, simpler interface has grown. Dry electrodes, which make direct contact with the skin without gel, promise exactly that: rapid setup and greater comfort.

But this convenience carries a physical cost. The absence of gel introduces higher impedance and a noisier signal, creating a consistent trade‑off between practicality and data fidelity. A body of recent independent research now maps the precise dimensions of that trade‑off, clarifying where dry electrodes perform admirably and where they remain a second choice.

Read article

How Does Home EEG Work for Daily Brain Recording?

Home EEG are self-administered recordings performed outside any clinical or laboratory setting. It hands the electrode gel, the headset, and the recording software to an untrained user, often with nothing more than a smartphone app for guidance. The concept consists of having brain measurement capabilities that fits into daily life, potentially recording sleep architecture, cognitive focus, or seizure patterns without the logistical burden of a hospital visit.

Read article

Neurofeedback Devices as Whole Systems

Imagine playing a video game where your controller is invisible—you steer with nothing but your own brainwaves. That idea sits at the core of neurofeedback, a technique that gives you a real‑time window into your brain’s activity and then teaches you to shift it.

A device picks up signals generated by your brain, most often using an electroencephalogram (EEG) that detects electrical patterns on the scalp, or occasionally a functional near‑infrared spectroscopy (fNIRS) sensor that tracks blood flow. Those raw signals are processed and turned into a simple game, a sound, or a moving figure on a screen. Through trial and error, your brain learns to produce the patterns that make the feedback go in the direction you want.

A lot of guides focus on the individual parts—the EEG electrodes, the wires, the software—but a device only succeeds when those pieces form a coherent whole. This introduction examines neurofeedback as an integrated system where signal processing, feedback design, and everyday usability combine to determine whether something genuinely helps.

Read article

Master EEG Setup: Pre-Recording Best Practices

What separates a clear, interpretable neural signal from a trace corrupted by muscle artifact or line noise is not a sophisticated post-hoc algorithm, but a systematic, chronological pipeline of preparatory steps. EEG setup, in this context, is not simply the act of placing an electrode cap on a participant. It is a disciplined sequence of biological, environmental, and electrical calibration procedures that collectively establish a stable, low-noise interface between the brain and the amplifier.

This article walks through the pre-recording workflow, synthesizing available evidence to demonstrate that careful participant briefing, scalp preparation, environmental shielding, reference montage selection, and baseline artifact screening form a non-negotiable chain of dependencies.

Read article